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ABSTRACT 
Objective:- To compare the  eff icacy of  l ignocain  wi th l ignocain and magnesium sulfate  for  
in travenous  regional  anes thesia .  Material  and methods : -  This  Ranodomized cont rol led  
tr ia l  was conducted a t  Bahawal  Victor ia  Hospi ta l ,  Bahawa lpur  and Ni shtar Hospi ta l  
Multan.  The pat ients  were divided in two equal  gr oups.  In group L,  55 pa tients  received 
Lignoca in alone  and in group M,  55 pat ients  rece ived l ignocaine  wi th magnes ium sulfa te .  
The two groups  were  compared for  the  eff icacy.  Results:- Mean VAS was 4.36 + 2.40 in  
group L and 3.55+ 2.47 in group M (p>0.05) .  The  eff icacy of  l ignocaine  alone  was  
observed in  21 (38.2%)  pa t ients  while  ef f icacy of  l ignocaine  with  magnesium was seen 
among in  32 (58.2%) pat ients .  p-va lue > 0.05.  Conclusions:- The use  of  magnesium a long 
with  l ignocaine i s  found  to  be more effec t ive  than l ignocaine a lone for  IVRA.    
Key words:- Intravenous  regiona l  anesthesia ;  l ignocaine ;  magnesium sulfa te   
 
INTRODUCTION                                                                                                                 
Pain i s  an unpleasant  sensor y and emot ional  exper ience  associated with actua l  or  potent ia l  
t i ssue damage or  descr ibed in term of  such damage .  The word “pain”  i s der ived f rom the  
Lat in word “Poena” meaning punishment.  Pain  l ike  pover ty i s  alwa ys  wi th us .  After  t he  
bi r th of  c ivi l izat ion,  i t  took man a  long t ime to ge t  around to doing something about  
al levia t ing pa in1 .  The  re l ief  of  pain  during surgery i s  the aim of  anaes thesia.  Any 
exper t ise requi red in this  f ie ld should  be extended into the  postopera t ive per iod
2
.   
Pos toperat ive pain i s a  common and chal lenging problem (upto 30% of  the pa t ients  suffe r  
from modera te to severe  pain af te r  surgery)
3 , 4
.  Uncontrol led post-opera t ive pain  
produces a  neurohumera l  response  with the re lease  of  cat echolamines and act iva t ion of  
the sympathe tic  nervous  syst em.  This  r esult s  i n  a  number  of  physiological  changes tha t  
lead to post -opera t ive  morbidi ty l ike  tachycardia ,  hyper tens ion,  anxiety,  a te lac tas is ,  
fear ,  s leep dis turbance,  prolonged hospi ta l  s tay and increase  in cost
3 , 4
.  Despi te  man y 
advances in pa in management,  i t  s t i l l  remains a ser ious  cause  of   
suffer ings  to the  pat ient .  The aim of  pos topera t ive  analges ia  i s  not  on ly to r educe  the  
pa in in tensi ty but  i s  al so to save  the pa t ient  f rom the s ide  effects  of  the  analgesic  drugs
5
.  
One area of  growing concern for  the  anesthes iologis t  involves the  per ioperat ive  
assessment and management of  the  per iopera t ive pain6 .  Effect ive  postoperat ive analges ia  
improves the  functioning of  the  organs fol lowing surge ry and shor tens the  hospital  
stay
7 , 8
.  Post  operat ive  pain  rel ie f  i s  a  ver y impor tant  part  of  ba lanced anaesthe tic  
technique  and if  not  control led in  t ime,  may adve rsely ef fec t  the  post  operat ive  
morbidi ty9 .   
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Regional  and general  anaes thesia a re commonly used for  surgica l  procedures.  General  
anaesthes ia re fer s t o the loss  of  abil i t y t o perce ive pa in associa ted wi th loss of  
consc iousness  produced by in travenous or  inha la t ion anaes the tic  agents 1 0 .  Genera l  
anes thesia involves  the  use of  th iopentone for  induc tion,  t r acheal  intubation fac i l i tated  
by suxamethonium, pos i t ive-pressure  vent i lat ion of the lungs with  a n i trous  
oxide/ox ygen mixture plus  a vola t i le  agent ,  and a  muscle re laxant .  The r isks  inc lude the  
aspi ra t ion of s tomach contents ,  awareness  of  the  surgical  procedure  (due  to  inadequate  
anaesthes ia) ,  fai led intubations ,  and respirator y problem1 1 .   
Regional  anesthesia is  the use  of  loca l  anesthe tics  to b lock sensat ions of  pain  f rom a 
large area of  the bod y,  such as  an arm or  leg or  the abdomen.  Regional  anes thesia a l lows  
a procedure  to be  perfor med on a region of  the  bod y wi thout  your  be ing unconsc ious 1 2 .   
In tavenous  regional  anesthesia  is  one  of  the safest  and most  rel iable forms of  anesthes ia  
for  shor t  surgica l  procedures  on upper  extremity
1 3
.  However,  i t  has  been l imi ted b y 
tourniquet  pain  and inabil i t y to provide  post  opera t ive  analges ia
1 4
.  An ideal  IVRA 
solution should have rapid onse t ,  reduced dose  of  local  anes the tic  and prolonged 
anes thesia
1 5
.  At  present  this  may only be  achieved by addi t ion of  va r ious adjuncts  to  
loca l  anesthe t ic  l ike morphine ,  fentanyl ,  clonidine,  t ramadol
1 6
 and NSAIDS l ike  
Ketorolac
1 7
.  Parentera l  Magnes ium has been used on an empir ical  basis as  an ant i  
dysr ythmic t reatment for  ec lampsia  and for  in t ra  operat ive and post  operat ive  analgesia .  
The mechanism of  ana lgesic  e ffec t  of  Magnesium is  not  c lea r but  in terference wi th 
calc ium channels  and N-methyl -d-a spar ta te seems to p lay an important  rol e
1 8
.   
In  a  s tudy b y Narang et  al ,  compared the ef fec t  of  magnesium sulfa te  as  an adjuvant  to  
l ignocain  in  30 pa itents  with  ASA physical  s ta tus  I  or  I I  pa t ients  undergoing upper  l imb 
surger y under  tournique t  receiving IVRA.  This  was a  double  bl ind randomized cl inica l  
t r ia l .  Assessment was by observing the  t ime of  onse t  of  sensory and motor  b lock and 
tourniquet  pain.  The pa tients  were divided in  two groups :  group L ( those who rece ived 
l ignocain) and group M ( those who received l ignocain wi th magnesium).  The mean t ime 
of onse t  of  sensor y block in l ignocain group was 12.40 and 3.47 minute  in gr oup L and 
M respective ly (P  < 0.001) .  The average  t imes of  onse t  of  motor  block in  groups  L and M 
were 17 and 6 minutes  respect ive ly (P  < 0.001) .  There was a s ta t i s t ica l ly s ignif ican t  
di f ference in visua l  analogue scale  for  t ourniquet  pa in a t  10 and 30 minutes  af te r  
tourniquet  inf la t ion.  At 10 minutes the mean VAS was 3 in goup L and 0  in group M, and 
at  30 minutes ,  i t  was 4 in group L and 3 in group M. No torniquet  pa in  was seen in 13.4  
% pati ents in group L and 33.3 % pat ients  in gr oup M. So,  i t  was concluded that  adjunct  
of magnesium sulfa te with l ignocain hastens the  onset  of  sensory and motor  block and 
decreases  tourniquet  pain ( improved VAS scores ) 1 9 .   
 
MATERIAL AND METHOD 
This  Randomized cont rolled  tr ia l  was conducted at  Bahawal Vic tor ia Hospi ta l ,  Bahawalpur  
and Nishtar  Hospi ta l  Mul tan.  The  pa t ients  were  divided in  two equal  groups.  In  group L,  
55 pat ients  received Lignocain  alone  and in  group M,  55 pa tient s r ece ived l i gnocaine  with  
magnesium sulfa te.  The  two groups were  compared for  the ef f icacy.  Chi-square  test  was  
applied for  sta t is t ica l  di f ference.  (p-value < 0 .05 was taken as  s igni f icant .  Data was  
collec ted on spec ia l  designed proforma.  
 
RESULTS                                                                                                                                  
In Group L,  the  mean age  of  the pa tients  was 35.93 + 8.77 yea rs  [ range 20 – 50] .  The re  
were  20 (36.4%)  pa tients  of  age  range  of  20 –  30 year s ,  15 (27.2  %) pa t ients  of  age  range  
of  31 –  40 year s  and 20 (36.4%) pa tients  of  age range  of  41 –  50 year s .  In  Group M,  the  
mean age  of  the pa t ients  was 35.65+8.09 yea rs  and age range  was 21 – 50 yea rs .  Of  the  55 
pa tients  in the study,  there  were  13 (23.6 %) patients  of  age  range of  20 – 30 years ,  28 
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(50.9 %) pat ients  of  age range of  31 – 40 year s and 14 (25.5 %) pa t ients  of age range of  
41 – 50 year s.   
 
In group L,  there were  36 (65.5%) male pa tients and 1 (34.5%) were female .  The female  to 
ma le  ra t io in  this  gr oup was 1:1.89.  In gr oup M,  there were 33 (60%)  male  pa tients and 22 
(40%) were  female .  The  female to male ra t io in th is group was 1:1.5.  The  pa t ients  were  
also distr ibuted according to American Society of  Anaes thesiologis t  Socie ty (ASA)  
Classif icat ion.  Only two classe s,  ASA Class  1 and ASA Class  2 were inc luded in the  
study.  In  gr oup L,  there  were 35 (63.6%) pa tients  who were inc luded in  ASA Class  1  and 
20 (36.4%)  pat ients  who were included in ASA Class 2.  In  group M,  38 (69.1%)  pa t ients  
and 17 (30.9%) pat ients were  included in ASA Class 1 and ASA Class 2,  respective ly.  The  
mean dose  of  t ramadol  consumed by the pat ients in group L was 4.36 + 2.40 and in group  
M was 3 .55+ 2.47.  The  two groups were  also compared for  any s tat i s t ica l  d if ference .  
Student  t - tes t  was appl ied and p > 0.05 which showed tha t  there was not  any s igni f icant  
di f ference  be tween the  two groups.  In  Group  L,  the re  were 34 (61.8%) pat ients  who 
suffered f rom tourniquet  pa in and 21 (38.2 %).  In  group M, there were 23 (41.8%) who 
suffered f rom tourniquet  pa in ,  while no pa in  was observed in 32 (58.2%) pa t ients .  In  
Group L,  l ignocain  was  found effect ive  in 21 (38.2%) pa tients while  i t  was not  ef fect ive  
among 34 (61.8%) pa tients.  In group M,  l ignocain with magnesium sulfate was found  
effec t ive  in 32 (58.2%) pa tients  while  i t  was not  ef fec t ive in 23 (41.8%) pa t ients .  The  two 
groups  were a lso compared wi th each other  for the  eff icacy.  Chi-square  test  was appl ied.  
There was no s tat is t ica l  di f ference  found between the two groups (p  > 0 .05) .  
 
DISCUSSION 
This  s tudy compared the e ff icacy of  l ignocain a lone ver sus l ignocain with magnesium 
sulfate  in IVRA and the resul ts  were in favor  of  l ignocain  wi th magnesium sulfate .  This  
was found effec t ive in 58.2% patients while  l ignocain a lone was found effec t ive in 38.2% 
(p < 0.05) .  In l i te ra ture,  there a re var ious studies  which have compared the  magnesium 
sulfate as an adjuvant  to the l ignocain with l ignocain a lone for  IVRA.  Kashef i  P ,  e t  al
2 0
 
compared the outcome of  l ignocain  a lone  wi th  l ignoc ian with magnesium sulfa te  for  t he  
IVRA for  upper l imb surger y.  The y inc luded 40 pa t ients  who were divided in two equa l  
groups .  One group receiving l ignocain  a lone  and other  rece iving l ignocain wi th  
magnesium sulfa te.  In  the ir  study,  the y s tudied the effec t  of  magnesium on var ious  
parameter s ,  l ike  sensory and motor  block onse t  and recover y t imes,  hemod ynamic  
var iables ,  tournique t  pa in ,  and analges ic use,  e tc .  They observed tha t  sensor y block onse t  
t ime  was s ignif icantly shor ter  in l ignoca in wi th  magenesium sul fa te  group (6.20 ±  2.35 
ver sus 4.10 ± 2 .22) .  Similar ly,  le ss  t ime was required in achieving motor  block (10.20 ±  
3.92 7.10 ±  2.61) .  The  tourniquet  pain calculated by VAS was 2  (1-4)  for l i gnocain alone  
and 1 (0-3) for  l ignocain wi th  magnes ium.  The result  was s igni f icant ly s ignif icant .  The  
tourniquet  pa in was a l so ca lcula ted by VAS in our s tudy.  However,  the VAS in both  
groups  was much higher  than the ir  s tudy i . e .  4.36 + 2.40 in l ignocain group and 3.55+  
2.47 in l ignocain wi th magnesium sulfate group.  This  may be due  to the reason that  in  
study b y Kashef i  P ,  et  a l .  20 cc of  l ignocain  was used which is  a lmost  a  higher  dose .  So,  
the overa l l  pa in  score  was low in their  s tudy.   
 
In  another  s tudy b y Narang S ,  e t  al
1 9
 the  l ignocain  was compared wi th  l ignocian wi th  
magnesium for  t he  IVRA.  This  s tudy was  conducted among 30 pat ients  who were  divided 
in  two equa l  groups .  In  this  s tudy,  the  asse ssment of  tourniquet  pain  score was done  on  
the bas is of  the visua l  analogue  sca le (VAS) (O=no pa in and 10=wors t  pain  imaginable) .  
When tournique t  pa in  was > 3  on the  VAS,  pati ents  were given fentanyl  1  [micro]  g/kg 
in travenous ly.  The  mean tourniquet  pa in  af te r  30 min was 4(1-9)  in l ignocaine  a lone  group  
and 3 (0-3)  in l ignocaine with magnesium sulfa te group.  P< 0.007 which was s tat is t ica l l y 
signi f icant .  The  findings of  this s tudy were al so s imilar  to that  wi th  our  s tudy in  tha t  
adding magnesium to l ignocaine i s  associated with less  tournique t  pa in  than l ignocaine  
alone.  However ,  in the i r  study,  an  interest ing observa tion was made.  They not iced tha t  
adding magnes ium to the l ignocaine may reduce the tournique t  pain  but  increases the  
frequency of  in ject ion pain .  They found that  of  the pa t ients  in  magnes ium with  l ignocaine  
group,  66.7% repor ted modera te to severe pa in whi le the drug was being in jected,  
compared to 20% in l ignocaine a lone group  (P=0.011).  The y conc luded tha t  adding 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.42, 2018 
 
78 
magnesium to l ignocaine in  IVRA may reduce the tourniquet  pa in but  may increase  the  
in ject ion pa in.   
 
Another  s tudy was conducted by Turan A,  e t  a l
1 4
 on  30 pat ients  undergoing IVRA.  The  
pa tients  were divided in  two equal  groups.  Of  the  other  var iable,  tourniquet  pain  was also 
calcula ted based on VAS.  It  was  found that  VAS scores  of  tournique t  pa in were lower  in  
magnesium with l ignoca ine group i . e .  min 3 (1–5)  as  compared to  l ignocaine  a lone group  
at  50 min i .e .   4  (2–6)  (P  < 0 .001)  
 
CONCLUSION                                                                                                            
The addit ion of  magnesium to l ignocaine in  IVRA demonst ra ted decreased tourniquet  pa in  
and bet ter  ef f icac y than l ignocaine  a lone.  So,  i t  i s  recommended that  magnesium sulfa te  
should  be  rout ine ly used for the  IVRA along with  l ignocaine  in  our  setup.  However ,  mult i-
cente r s tudie s for  a  longer  per iod are  requi red to  be tter  e s t imate  of  outcomes.   
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